Zheng Xing Xing Ye Ri Bao·2026-01-22 09:01Market Overview - The chemical pharmaceutical sector experienced a decline of 1.01% on January 22, with Yifang Bio leading the drop [1] - The Shanghai Composite Index closed at 4122.58, up 0.14%, while the Shenzhen Component Index closed at 14327.05, up 0.5% [1] Stock Performance - Notable gainers in the chemical pharmaceutical sector included: - Dongya Pharmaceutical (605177) with a closing price of 22.95, up 6.89% [1] - Warner Pharmaceuticals (688799) at 50.35, up 6.52% [1] - Haixin Co. (600851) at 8.00, up 5.26% [1] - Conversely, Yifang Bio (688382) saw a significant decline of 6.03%, closing at 25.87 [2] - Other notable decliners included: - Xingqi Eye Medicine (300573) down 5.27% at 78.36 [2] - Dize Pharmaceutical (688192) down 4.43% at 59.05 [2] Capital Flow - The chemical pharmaceutical sector experienced a net outflow of 1.78 billion yuan from institutional investors, while retail investors saw a net inflow of 1.6 billion yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Individual Stock Capital Flow - Key stocks with significant capital flow include: - Tonghua Golden Horse (000766) with a net inflow of 32.99 million yuan from institutional investors [3] - Yifang Bio (688382) had a net outflow of 9.61 million yuan from institutional investors [3] - Haixin Co. (600851) saw a net inflow of 18.22 million yuan from institutional investors [3]